Positive selection and transplantation of peripheral CD34+ progenitor cells: Feasibility and purging efficacy in pediatric patients with neuroblastoma

Journal of Hematotherapy and Stem Cell Research

Volumn 6, Issue 3, 1997, Pages 235-242

  Handgretinger, R ^a,d   Greil, J ^b   Schurmann U ^a   Lang, P ^a   Gonzalez Ramella, O ^a   Schmidt, I ^a   Fuhrer R ^c   Niethammer, D ^a   Klingebiel, T ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b UNIVERSITY HOSPITAL ERLANGEN   (Germany)

^c Im Dr von Haunerschen Kinderspital   (Germany)

^d UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CD34 ANTIGEN;

ARTICLE; CANCER CHEMOTHERAPY; CAUSE OF DEATH; CELL ISOLATION; CELL SELECTION; CHILD; CHILDHOOD CANCER; CLINICAL ARTICLE; HUMAN; LEUKAPHERESIS; NEUROBLASTOMA; PRIORITY JOURNAL; SEPSIS; STEM CELL TRANSPLANTATION;

ANIMALS; ANTIGENS, CD34; ANTINEOPLASTIC AGENTS; CELL SEPARATION; CHILD; CHILD, PRESCHOOL; COMBINED MODALITY THERAPY; FEASIBILITY STUDIES; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMATOPOIETIC STEM CELLS; HUMANS; INFANT; LEUKAPHERESIS; MALE; MICE; NEOPLASM CIRCULATING CELLS; NEUROBLASTOMA; TRANSPLANTATION, AUTOLOGOUS;

EID: 0030854884     PISSN: 15258165     EISSN: None     Source Type: Journal    
DOI: 10.1089/scd.1.1997.6.235     Document Type: Article

References (31)

1. Gale, R.P., Henon, P. & Juttner, C. Blood stem transplants come of age. Bone Marrow Transplant. 9:151, 1992.
2. Leibundgut, K. Autotransplants with peripheral blood stem cells and clinical results obtained in children: A review. Eur. J. Pediatr. 152:546, 1993.
3. Brugger, W., Bross, K., Glatt, M., et al. Mobilization of tumor cells and hematopoietic cells into peripheral blood of patients with solid tumors. Blood 83:636, 1994.
4. Moss, T.J. & Ross, A.A. The risk of tumor cell contamination in peripheral blood stem cell collections. J. Hematother. 1:225, 1992.
5. Brenner, M.K., Rill, D.R., Moen, R.C., et al. Gene-marking to trace origin of relapse after autologous bone marrow transplantation. Lancet 341:85, 1993.
6. Brenner, M.K. & Rill, D. Gene-marking to improve the outcome of autologous bone marrow transplantation. J. Hematother. 3:85, 1994.
7. Rill, D.R., Santana, V.M., Roberts, W.M., et al. Direct demonstration that autologous bone marrow transplantation for solid tumors can return a multiplicity of tumorigenic cells. Blood 84:380, 1994.
8. Pritchard, J. Megatherapy for advanced neuroblastoma-rationale and role. Eur. J. Cancer 31A:134, 1995.
9. Gee, A.P., Van Hilten, J., Graham-Pole, J., et al. Antibody-complement killing of neuroblastoma cells. Prog. Clin. Biol. Res. 175:471, 1985.
10. Reynolds, C.P., Seeger, R.C., Vo. D.D., et al. Model system for removing neuroblastoma cells from bone marrow using monoclonal antibodies and magnetic immunobeads. Cancer Res. 46:5882, 1986.
11. Kemshead, J.T., Heath, L., Gibson, F.M., et al. Magnetic microspheres and monoclonal antibodies for the depletion of neuroblastoma cells from bone marrow: Experiences, improvements and observations. Br. J. Cancer 54:771, 1986.
12. Sieber, F., Rao, S., Rowley, S.D., et al. Dye-mediated photolysis of human neuroblastoma cells: Implications for autologous bone marrow transplantation. Blood 68:32, 1986.
13. Shpall, E.J., Jones, R.B., Bearman, S.I., et al. Transplantation of enriched CD34-positive autologous marrow into breast cancer patients following high-dose chemotherapy: Influence of CD34-positive peripheral-blood progenitors and growth factors on engraftment. J. Clin. Oncol. 12:28, 1994.
14. Brugger, W., Henschler, R., Heimfeld, S., et al. Positively selected autologous blood CD34+ cells and unseparated peripheral blood progenitor cells mediate identical hematopoietic engraftment after high-dose VP16, ifosfamide, carboplatin, and epirubicin. Blood 84:1421, 1994.
15. Shpall, E.J., Jones, R.B., Bearman, S.I., et al. Transplantation of CD34+ hematopoietic progenitor cells. J. Hematother. 3:145, 1994.
16. Berenson, R.J., Bensinger, W.I., Hill, R.S., et al. Engraftment after infusion of CD34+ marrow cells in patients with breast cancer or neuroblastoma. Blood 77:1717, 1991.
17. Berthold, F., Burdach, S., Kremens, B., et al. The role of chemotherapy in the treatment of children with neuroblastoma stage IV: The GPO (German Pediatric Oncology Society) experience. Klin. Pädiatr. 202:262, 1990.
18. Handgretinger, R., Klingebiel, T., Baden, B., et al. Stem cell mobilization, collection and transplantation in pediatric patients. Cancer Res. Ther. Control 3:43, 1992.
19. Handgretinger, R., Klingebiel, T., Herter, M., et al. Comparative analysis of peripheral stem cells collected and transplanted in combination with granulocyte-macrophage and granulocyte colony-stimulating factor. Prog. Clin. Biol. Res. 389:479, 1994.
20. Klingebiel, T., Handgretinger, R., Herter, M., et al. Peripheral blood stem cells (PBSC) as stem cell source in children and young adults after myeloablative treatment: Nonrandomized comparison between GM-CSF and G-CSF for mobilization. J. Hematother. 4:307, 1995.
21. Schultz, G., Cheresh, D.A., Varki, N.M., et al. Detection of ganglioside GD2 in tumor tissue and sera of neuroblastoma patients. Cancer Res. 44:5914, 1984.
22. Takaue, Y., Watanabe, T., Kawano, Y., et al. Isolation and storage of peripheral blood hematopoietic stem cells for autotransplantation into children with cancer. Blood 74:1245, 1989.
23. Demeocq, F., Kanold, J., Chassagne, J., et al. Successful blood stem cell collection and transplant in children weighing less than 25 kg. Bone Marrow Transplant. 13:43, 1994.
24. Handgretinger, R., Klingebiel, T., Dopfer, R., et al. Peripheral stem cell collection and transplantation in pediatric patients. Prog. Clin. Biol. Res. 377:615, 1992.
25. Lasky, L.C., Fox, S.B., Smith, J., et al. Collection and use of peripheral blood stem cells in very small children. Bone Marrow Transplant. 7:281, 1991.
26. Brugger, W., Bross, K.J., Glatt, M., et al. Mobilization of tumor cells and hematopoietic progenitor cells into peripheral blood of patients with solid tumors. Blood 83:636, 1994.
27. Brugger, W., Heimfeld, S., Berenson, R.J., et al. Reconstitution of hematopoiesis after high-dose chemotherapy by autologous progenitor cells generated ex vivo. N. Engl. J. Med. 333:283, 1995.
28. 131I-M]IBG. Prog. Clin. Biol. Res. 385:309, 1994.
29. Niethammer, D. & Handgretinger, R. Clinical strategies for the treatment of neuroblastoma. Eur. J. Cancer 31A:568, 1995.
30. Handgretinger, R., Anderson, K., Lang, P., et al. A phase I study of human/mouse chimeric anti-ganglioside GD2 antibody ch 14.18 in patients with neuroblastoma. Eur. J. Cancer 31:261, 1995.
31. Hartmann, O., Benhamou, E., Beaujean, F., et al. Repeated high dose chemotherapy followed by purged autologous bone marrow transplantation as consolidation therapy in metastatic neuroblastoma. J. Clin. Oncol. 5:1205, 1987.